Searched for
GENERIC ANXIETY DRUG
Zydus gets Chinese health regulator nod for generic anxiety drugZydus Lifesciences has secured approval from China's National Medical Products Administration (NMPA) for its Venlafaxine extended-release c...- Alembic Pharma gets USFDA nod for generic drug to treat depression, anxietyAlembic Pharmaceuticals Ltd. announced it has secured final approval from the USFDA for its generic Paroxetine extended-release tablets, av...
- JB Chemicals gets USFDA nod to market generic medicationJB Chemicals & Pharmaceuticals on Wednesday received approval from the US health regulator to market a generic product, used to treat mood ...
- Glenmark gets USFDA nod for generic antipsychotic drugThe company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP,...
- Lupin launches generic anti-depression drug in USThe company "announced the launch of generic paxil CR extended release tablets, 12.5 mg, 25 mg and 37.5 mg, having received an approval fro...
- Lupin launches 40 mg Duloxetine DR capsules in the USLupin is now the only generic manufacturer to offer all Duloxetine dosage strengths - the 20 mg, 30 mg, 60 mg, and now the newest 40 mg.
- PCV Lux SCA buys 1.2 per cent stake in Strides Arcolab for about Rs 50 croreStrides Arcolab had received approval from US health regulator for its generic Buspirone Hydrochloride tablets used for treating anxiety di...
- Strides gets United States Food & Drug Administration nod for generic anti-anxiety tablets"The product will be manufactured at the company's oral dosage facility at Bangalore and marketed directly by Strides in the US Market."
- Dr Reddy's Lab launches duloxetine delayed-release capsulesCymbalata (duloxetine delayed- release capsules) brand and generic had US sales of $5.04 billion for the most recent 12 months ending April...
- Sun Pharma gets USFDA nod for anti-depressant drugThe company said its subsidiary has received nod from the US Food and Drug Administration to market Duloxetine Delayed-Release Capsules.
- Several Indian companies get FDA nod for anti-depressant drugThe US Food and Drug Administration has approved the first generic versions of Cymbalta, a prescription medicine used in treatment of depre...
- Lupin receives USFDA nod for Lorazepam Oral ConcentrateDrug firm Lupin said it has received US health regulator's approval to market its generic Lorazepam Oral Concentrate in American market.
- Regulatory energies should focus on spurious drugs, unethical practicesThe government has done well to assuage the uninformed anxiety over foreign buyouts of domestic drug companies.
- Natco Pharma bags licence to sell Nexavar drug; stock upShares of Natco Pharma extended gains for the second straight day on Tuesday after the company reported that it had received a license for ...
- Wockhardt gets USFDA tentative nod to sell anti-depressantDrug firm Wockhardt said it has received tentative approval from USFDA to market generic Duloxetine Hydrochloride capsules, used for treati...
- Dr Reddy’s Labs launches three generic products in USADr Reddy’s Laboratories announced today that it launched three generic drugs in the US market.
- Sun Pharma receives USFDA nod for Venlafaxine tabletsSun Pharmaceuticals Industries Ltd has received USFDA's approval to market a generic version of Venlafaxine Hydrochloride Extended Release ...
- Sun Pharma receives USFDA nod for anti-anxiety drugSun Pharmaceutical Industries today said that it has received the US Food and Drug Administration's nod to market a generic version of alpr...
- Aurobindo Pharma surges 13% on USFDA nodShares of Aurobindo Pharma extended gains after the company received US administration's approval for Sertraline Hydrochloride oral concent...
- Generics market may lose value on margin cutThe proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...
Load More
